ACE and aortic stenosis: The Ramipril in Aortic Stenosis (RIAS) trial examined the potential of ACE inhibitor therapy to reduce LV hypertrophy in AS and showed no significant difference in AS progression at 12 months compared with placebo, however, a significant difference in blood pressure between groups was not achieved either (127).